Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Cabio Biotech (Wuhan) Co., Ltd.
Sector
Healthcare
Industry
Biotechnology
Employees
595
First IPO Date
December 19, 2019
Key Executives
| Name | Title | Pay | Year Born |
| Huabiao Wang | Chief Financial Officer & Director | 0 | 1965 |
| Huarong Yi | Employee Director, Deputy GM & Secretary of the Board of Directors | 0 | 1976 |
| Hao Xiong | Head of Accounting Department | 0 | N/A |
| Anfeng Geng | Deputy General Manager | 0 | 1976 |
| Xiangyu Li | Deputy General Manager | 0 | 1978 |
| Zhi Bo Li | Deputy General Manager | 0 | 1973 |
| Dewei Yi | Chairman & GM | 0 | 1965 |
AD
Description
Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development, production and sale of polyunsaturated fatty acids and nutrition products. Its products include arachidonic acids (ARA), docosahexaenoic acids (DHA), natural beta-carotene products, infant formula food, functional healthcare food and dietary supplements. The company was founded on September 22, 2004 and is headquartered in Wuhan, China.
AD
